05:33 PM EST, 11/21/2025 (MT Newswires) -- Joseph P Lyssikatos, Chief Scientific Officer, on November 19, 2025, sold 12,500 shares in Enliven Therapeutics ( ELVN ) for $279,155. Following the Form 4 filing with the SEC, Lyssikatos has control over a total of 902,688 common shares of the company, with 902,688 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1672619/000196715025000007/xslF345X05/form4-11212025_101158.xml ...

05:34 PM EST, 11/21/2025 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on November 20, 2025, sold 8,000 shares in United Therapeutics ( UTHR ) for $3,812,082. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 644,489 common shares of the company, with 130 shares held directly and 644,359 controlled indirectly. SEC...

(Reuters) -Billionaire investor Bill Ackman is aiming to publicly list hedge fund company, Pershing Square Capital Management, early next year, the Financial Times reported on Friday, citing two people briefed on the matter. Talks for the listing are at a preliminary stage and could ultimately be delayed or not lead to a public offering depending on the market conditions, the...

Nov 21 (Reuters) - Billionaire investor Bill Ackman is aiming to publicly list hedge fund company, Pershing Square Capital Management, early next year, the Financial Times reported on Friday, citing two people briefed on the matter. (Reporting by Ateev Bhandari in Bengaluru; Editing by Arun Koyyur) ...